Status:
UNKNOWN
The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye
Lead Sponsor:
Peking University Third Hospital
Conditions:
Dry Eye
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to observe the effect of 0.05% cyclosporine eyedrops combined with artificial tears in patients with dry eyes after corneal refractive surgery and to observe the changes i...
Detailed Description
The purpose of this study is to observe the effect of 0.05% cyclosporine eyedrops combined with artificial tears in patients with dry eyes after corneal refractive surgery and to observe the changes i...
Eligibility Criteria
Inclusion
- Patients who suffering from dry eye after refractive surgery with age between 18 and 45 years old.
- Any gender.
- Provision of written informed consent.
Exclusion
- active ocular infection, ocular inflammation, active ocular allergy, severe blepharitis or obvious inflammation of the eyelid margin.
- Pregnant and lactating women, or those planning a pregnancy over the course of the study.
- Uncontrolled systemic disease.
- Suffer from diseases that may affect corneal nerves, such as keratoconus, trigeminal neuralgia, allergic conjunctivitis, etc.
Key Trial Info
Start Date :
August 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06043908
Start Date
August 31 2022
End Date
December 31 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Qi
Beijing, Beijing Municipality, China, 100191